The only cervical device
clinically proven to reduce pain during transcervical procedures

CarevixTM  is a single-use cervical stabilizer, engineered with vacuum technology, fully designed to deliver atraumatic transcervical access

Carevix™ is currently FDA-Cleared and CE-Marked. Available for commercialization.
Scroll to learn more

Scroll to learn more


Group 1267


Significantly reduces pain and bleeding during cervical engagement while delivering robust traction and maneuverability*
* Yaron, M., et al. An Innovative Atraumatic Uterine Cervical Traction Device: A Randomized Trial. Poster presented at: European Society of Contraception and Reproductive Health. Ghent - Belgium, May 2022.
Group 1267


Engineered for ease of use and to mimic current clinical practice requiring minimal learning curve*
* Aspivix Data on File .
Group 1267


Designed to be used in various transcervical procedures, e.g., IUD, Dx Hysteroscopy, IVF.*
* Aspivix Data on File .


Breakthrough suction technology for atraumatic procedures

Ergonomic handle for precise grip

Single button operation for easy deployment

Anatomical and soft lip for gentle cervical touch

Pull the piston to generate the vacuum & rotate to lock it. 

Place the suction head on the cervix & press the button downwards to deliver the vacuum. 

Press the button upwards to release the cervix.

Play Video

Clinical Evidence

ADVANCE Women Study (Atraumatic Device using VAcuum Technology for CErvical Procedures in Women)

Group 1707@2x

Study Format

Randomized controlled trial (RCT), comparing the efficacy and safety of Aspivix device and the standard of care (tenaculum) in intrauterine contraception devices (IUD) procedures.

Primary Endpoint

Patient-reported pain scores (VAS) at specific time points during IUD insertion procedure.

2Icon_Light-Yellow-Dark-Magenta_12 copy

2 Centers in Switzerland

  • University Hospital of Lausanne (CHUV)
  • University Hospitals of Geneva (HUG)

Clinical Investigators

  • Prof Patrice Mathevet, CHUV
  • Dr. Hélène Legardeur, CHUV
  • Dr. Michal Yaron, HUG
  • Dr. Bastien Barcellini, HUG
  • Dr. Farida Akhoundova, HUG
2Icon_Light-Yellow-Dark-Magenta_6 copy@2x


Enrollment completed in February 2022


Preliminary Results presented at European Society of Contraception in May 2022 - Link to the Press Release

For CLINICAL STUDIES WITH Aspivix Device please visit

Clinical Applications


Carevix is indicated for use in various transcervical procedures, such as:

Intrauterine device procedures IUD



Fertility procedures

Are you interested in
being part of the change?